ASX
Clinuvel Pharmaceuticals Limited
CUV:ASX•Healthcare
Sensitive ASX Announcement
Clinuvel commences US Phase III trial of SCENESSE
Published: 22/05/12, 05:57pm (AEST)•3 pages